GHTC

Celebrating partnerships & policymakers
driving global health innovation

Scroll Down
Innovating for Impact
Nominations are now open for the 2021 Innovating for Impact Awards
Submission deadline is July 30
Learn More

About the Innovating for Impact Awards

The Innovating for Impact Awards honor the multisector partnerships and policymakers helping to transform breakthrough scientific research into lifesaving drugs, diagnostics, vaccines, and other health tools for unmet global health challenges.

The initiative annually recognizes one research partnership that has advanced a game-changing global health technology and two US Members of Congress whose actions have furthered policies and political will to accelerate innovation to tackle the world’s most threatening diseases and health conditions.

  • John Boozman

    2020 Honoree 2020 Honoree

    Senator John Boozman

    Congressional Champion Award

    During his two decades in Congress, Senator Boozman has been a steadfast and influential champion for global health, often working outside the spotlight to foster support among his Republican colleagues. He founded what is today the Congressional Malaria and Neglected Tropical Diseases Caucus and has consistently leveraged his committee roles to advance resources for global health innovation. As a member of the State and Foreign Operations Appropriations Subcommittee, he has fought to defend and grow funding for global health programs, and through the Defense Appropriations Subcommittee, has worked to protect Army and Navy malaria research programs.

    As COVID-19 has devastated the world and challenged global solidarity, the senator has remained unwavering in his commitment to global health and international cooperation. He has maintained his position that the United States should continue working with the World Health Organization, despite rising political discord, and has strived to advance emergency funding for the global COVID-19 response. “The American people have always risen to the challenge to help our global neighbors,” he has said. “We have moral responsibility to respect the dignity of all human beings no matter what country they call home.”

  • Quote

    American values guide the desire to continue to promote effective programs that save lives and build goodwill for the US around the globe. Not only is it the right thing to do, but it is also in our national security interest.

    Senator John Boozman
    Congressional Champion Honoree

  • Patty Murray

    2020 Honoree 2020 Honoree

    Senator Patty Murray

    Congressional Champion Award

    “In a world as connected as ours, one of the best ways to keep our country safe is to continue US leadership on global health security,” Senator Murray has stated, underscoring the intersections between domestic and global health. Through her leadership positions on the Appropriations and Health, Education, Labor, and Pensions Committees, the Senator has worked tirelessly to advance a healthier, safer world through innovation. She has fought passionately to protect and expand funding for the National Institutes of Health, Centers for Disease Control and Prevention, and infectious disease research at the Department of Defense, and helped elevate research against emerging infectious diseases and antimicrobial resistance at the Biomedical Advanced Research and Development Authority through its reauthorization last year.

    As the world has confronted an accelerating sequence of global health emergencies, from Ebola to Zika to COVID-19, Senator Murray has worked with colleagues across the aisle to mobilize critical resources to respond to these crises and consistently championed evidence-based action over fear and global cooperation over nationalism. “As long as COVID-19 is surging in any country, it is a threat to every country…Diseases are not stopped by borders…they are stopped by robust public health efforts,” she has stated.

  • Quote

    These funding increases reflect a sustained commitment to invest in medical research with the goal of achieving breakthroughs that benefit all of us—including those who have been historically under-represented in clinical research—and preserve our nation's leadership in biomedical research.

    Senator Patty Murray
    Congressional Champion Honoree

  • CARB-X

    2020 Honoree 2020 Honoree

    CARB-X

    Partnership Award

    Honoring: CARB-X; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary of Preparedness and Response; Wellcome Trust; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Global AMR Innovation Fund, UK Department of Health and Social Care; German Federal Ministry of Education and Research; Bill & Melinda Gates Foundation; Boston University

    Antibiotic-resistant bacteria—often called superbugs—kill more than 700,000 people each year and could kill as many as 10 million annually by 2050 and force 24 million into poverty if this dangerous trend is not slowed. While new antibiotics and other tools are urgently needed to address drug-resistant bacterial infections, their development has not kept pace with rising resistance, and many pharmaceutical companies have abandoned antibacterial research and development due to low profit potential, leaving a precariously thinning research pipeline. To confront this deepening crisis, in 2016, the US government—via the Biomedical Advanced Research and Development Authority and the National Institute of Allergy and Infectious Diseases—and Wellcome Trust joined together to launch CARB-X, a global nonprofit partnership dedicated to accelerating antibacterial research to address the most serious drug-resistant bacteria..

    Led by Boston University and supported by additional global partners, CARB-X provides an innovative suite of funding, scientific expertise, and business support to help companies bring new antibiotics, vaccines, rapid diagnostics, and other products to market. Since its inception, it has supported 75 diverse projects across ten countries with its portfolio now representing the world’s largest early development pipeline of antibacterial innovations. With several of these projects progressing and meeting research milestones on the path to regulatory approval, CARB-X is fueling an expanding pipeline of next-generation tools to respond to this urgent health threat.

  • Quote

    COVID-19 has taught us the terrible cost of pandemics. As we struggle with COVID-19, we must also prepare for future threats like antimicrobial resistance to avoid repeating our mistakes. Fortunately, CARB-X and many others have been hard at work since 2016, providing both funds and scientific guidance to strengthen the fragile pipeline.

    Kevin Outterson
    Executive Director, CARB-X

    Quote

    The CARB-X initiative plays an important role in BARDA’s goal to catalyze the early stage development pipeline and enhance our national health security preparedness. CARB-X allows BARDA to tap into a partnership of co-funders, accelerators, and innovators who are pushing critical novel antimicrobials from discovery to the market to address the public health and national security concerns of antibiotic-resistant bacteria.

    Dr. Gary Disbrow
    Director, Biomedical Advanced Research and Development Authority

Meet our Past Honorees

Congresswoman Anna Eshoo
Congresswoman
Anna Eshoo

Congressional Champion Award

View More
Congressman Mario Diaz-Balart
Congressman
Mario Diaz-Balart

Congressional Champion Award

View More
Senator Roy Blunt
Senator
Roy Blunt

Congressional Champion Award

View More
Congresswoman Rosa DeLauro
Congresswoman
Rosa DeLauro

Congressional Champion Award

View More
Congressman Tom Cole
Congressman
Tom Cole

Congressional Champion Award

View More
Senator Chris Coons
Senator
Chris Coons

Congressional Champion Award

View More